- Home
- PBYI vs FRAF Comparison
PBYI vs FRAF Comparison
Compare PBYI & FRAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- FRAF
- Stock Information
- Founded
- PBYI 2010
- FRAF 1906
- Country
- PBYI United States
- FRAF United States
- Employees
- PBYI N/A
- FRAF N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- FRAF Major Banks
- Sector
- PBYI Health Care
- FRAF Finance
- Exchange
- PBYI Nasdaq
- FRAF Nasdaq
- Market Cap
- PBYI 152.4M
- FRAF 173.6M
- IPO Year
- PBYI N/A
- FRAF N/A
- Fundamental
- Price
- PBYI $3.28
- FRAF $38.40
- Analyst Decision
- PBYI Strong Buy
- FRAF
- Analyst Count
- PBYI 1
- FRAF 0
- Target Price
- PBYI $7.00
- FRAF N/A
- AVG Volume (30 Days)
- PBYI 375.3K
- FRAF 14.3K
- Earning Date
- PBYI 05-08-2025
- FRAF 07-22-2025
- Dividend Yield
- PBYI N/A
- FRAF 3.44%
- EPS Growth
- PBYI 143.51
- FRAF N/A
- EPS
- PBYI 0.77
- FRAF 2.62
- Revenue
- PBYI $232,709,000.00
- FRAF $71,310,000.00
- Revenue This Year
- PBYI N/A
- FRAF N/A
- Revenue Next Year
- PBYI N/A
- FRAF N/A
- P/E Ratio
- PBYI $4.25
- FRAF $14.64
- Revenue Growth
- PBYI 2.68
- FRAF 5.61
- 52 Week Low
- PBYI $2.23
- FRAF $26.00
- 52 Week High
- PBYI $4.13
- FRAF $40.76
- Technical
- Relative Strength Index (RSI)
- PBYI 52.36
- FRAF 50.77
- Support Level
- PBYI $3.14
- FRAF $38.60
- Resistance Level
- PBYI $3.45
- FRAF $39.42
- Average True Range (ATR)
- PBYI 0.19
- FRAF 0.44
- MACD
- PBYI 0.01
- FRAF -0.15
- Stochastic Oscillator
- PBYI 51.19
- FRAF 8.70
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About FRAF Franklin Financial Services Corporation
Franklin Financial Services Corp is a bank holding company based in the United States. It is engaged in general commercial, retail banking and trust services normally associated with community banks. It offers a broad range of banking services to businesses, individuals and governmental entities which includes accepting and maintaining cheques, savings, and time deposit accounts, providing investment and trust services, making loans and providing safe deposit facilities. The bank also performs personal, corporate, pension and fiduciary services through its Investment and Trust Services Department.